Shanghai haohai biological technology announced that shareholder Lou Guoliang, due to personal financial needs, plans to reduce his shareholding in the company by no more than 0.8 million shares through centralized bidding and block trading within three months after three trading days from the date of this announcement, accounting for no more than 0.3416% of the company's total equity.
昊海生科:股东楼国梁计划减持不超过80万股
Shanghai haohai biological technology: Shareholder Lou Guoliang plans to reduce his shareholding by no more than 0.8 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.